2023 Annual Review
Our 2023 Annual Review explores progress on our innovative finance agreements, key milestones reached across the year, and our latest impact data.
Learn more about how our market shaping work is accelerating access to healthcare products.
Read Annual Review
Read Annual report & financial statements
28 June 2024
Globally, there is a stark and pervasive inequality in access to health products. At MedAccess, we aim to break down barriers preventing lifesaving innovations from reaching those who need them most. We are deeply committed to achieving this goal by facilitating partnerships between the makers and buyers of medical products to lower prices and stabilise supply.
We are fortunate to work with some of the most innovative businesses and organisations in global healthcare. In 2023, we made great progress with our existing partners and continued to build the foundations of potential partnerships that we are excited to see develop in the future.
We are at a critical time in global health. The world faces several significant challenges such as climate change, antimicrobial resistance, and the threat of future pandemics, which will require collective action. The road ahead is long but, together with our partners, we can make progress.
Our impact
We are pleased to share our key impact highlights to the end of 2023. Since we were formed in 2017, our agreements have:
- helped 539 million people access vaccines, diagnostics, medicines and other health technologies.
- supported partnerships that have benefitted people living in over 110 low- and middle-income countries.
- enabled suppliers to offer their products at lower prices, leading to $108 million in savings for purchasers.
Read Annual Review
Read Annual report & financial statements
